During his PhD, Josh explored magnetic materials for implantable bioelectronics and applied them toward developing wireless neural interfaces.
As a Schmidt Science Fellow, Josh has pivoted to Synthetic Biology where he will push the boundaries for wireless control of cell function and biology in the Shapiro Lab at the California Institute of Technology. He aims to develop next-generation cell therapies for greater functionality and programmability to treat diseases such as neurodegeneration.
As lifespans increase, diseases such as Alzheimer’s or dementia become more prevalent and new unprecedented healthcare challenges may arise. His work in developing biotechnologies will enable new tools in synthetic biology and treatments to ensure quality of life in an aging population. Josh is also passionate about supporting the community around him and working toward building an equitable scientific future.